Implementing central statistical monitoring (CSM) in a risk-based monitoring model
In this case study, one biopharmaceutical company transitioned its clinical study portfolio to a risk-based monitoring model and sought expert guidance to implement central statistical monitoring (CSM) in support of this new approach. Identifying biostatistics resources in the clinical research industry is relatively easy, but it was imperative for this company to find the right expert to create complex statistical algorithms that would detect data outliers and anomalies across multi-site clinical trial conduct and many different sources of patient data.
Related Insights
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Video
Part 2: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Video
Part 1: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 1: Risk-based Quality Management (RBQM) Video Series
Nov 11, 2021
Related Insights
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Video
Part 2: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Video
Part 1: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 1: Risk-based Quality Management (RBQM) Video Series
Nov 11, 2021